HMA Capital Partners is a Michigan-based capital investment fund that focuses on publicly financed healthcare programs in America.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 4, 2010
Consumer Health Advisers
|
Series B | $825.48K | Health Care | Yes |
Sep 8, 2009
Consumer Health Advisers
|
Series A | $1.15M | Health Care | Yes |
Jul 20, 2008
Celleration
|
Series D | $30M | Health Care | — |
Dec 20, 2006
RedPath Integrated Pathology
|
Series A | $6.50M | Biotechnology | — |
HMA Capital Partners has had 3 exits. HMA Capital Partners most notable exits include Celleration , RedPath Integrated Pathology
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Feb 3, 2015 | Celleration | M&A | Health Care | Detail |
Nov 3, 2014 | RedPath Integrated Pathology | M&A | Biotechnology | Detail |
Nov 1, 2013 | Consumer Health Advisers | M&A | Health Care | Detail |